Dr. Anthony Serianni
Anthony Serianni is currently Professor of Chemistry and Biochemistry at the University of Notre Dame and Chief Executive Officer of Omicron Biochemicals, Inc. He received his Ph.D. in Biochemistry from MSU in 1980, with Dr. Robert Barker, Professor and Chair of Biochemistry, as his mentor. In 1982, Drs. Barker and Serianni co-founded Omicron Biochemicals, a company specializing in the synthesis of stable isotopically-labeled carbohydrates and carbohydrate derivatives (e.g. nucleosides) for applications in a wide range of chemical, biochemical, biomedical, and clinical studies. Research in the Serianni laboratory is interdisciplinary in nature, requiring the development of new synthetic strategies for incorporation of stable isotopes into biomolecules, the application of advanced multidimensional NMR methods to decipher the inherently complex NMR spectra, and the development of new experimental approaches for relating NMR parameters with molecular behavior and new theoretical approaches for obtaining information not readily obtainable by direct experimental methods. Tony has served as Chairman of the American Chemical Society's Division of Carbohydrate Chemistry, as well as on the editorial board of Carbohydrate Research and the Journal of Carbohydrate Chemistry.